_version_ 1784670974890737664
author Kırcalı, Ekin
Ermiş, Gül Yavuz
Öztürk, Cemaleddin
Yilmaz, Hülya
Seval, Guldane Cengiz
Yıldırım, Yasin
Bozdag, Sinem Civriz
Toprak, Selami Kocak
Topcuoglu, Pervin
Ilhan, Osman
Beksac, Meral
Gurman, Gunhan
Yuksel, Meltem Kurt
author_facet Kırcalı, Ekin
Ermiş, Gül Yavuz
Öztürk, Cemaleddin
Yilmaz, Hülya
Seval, Guldane Cengiz
Yıldırım, Yasin
Bozdag, Sinem Civriz
Toprak, Selami Kocak
Topcuoglu, Pervin
Ilhan, Osman
Beksac, Meral
Gurman, Gunhan
Yuksel, Meltem Kurt
author_sort Kırcalı, Ekin
collection PubMed
description
format Online
Article
Text
id pubmed-8930036
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-89300362022-03-18 Is It Safe to Continue Allogeneic Hematopoietic Cell Transplantation Via Cryopreservation during COVID-19 Pandemic? Kırcalı, Ekin Ermiş, Gül Yavuz Öztürk, Cemaleddin Yilmaz, Hülya Seval, Guldane Cengiz Yıldırım, Yasin Bozdag, Sinem Civriz Toprak, Selami Kocak Topcuoglu, Pervin Ilhan, Osman Beksac, Meral Gurman, Gunhan Yuksel, Meltem Kurt Transplant Cell Ther Poster Session - Graft Sources - Related, Matched and Mismatched Unrelated, Haplo, Autologous, Cord Blood, Bone Marrow and Peripheral Blood American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. 2022-03 2022-03-18 /pmc/articles/PMC8930036/ http://dx.doi.org/10.1016/S2666-6367(22)00500-0 Text en Copyright © 2022 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Poster Session - Graft Sources - Related, Matched and Mismatched Unrelated, Haplo, Autologous, Cord Blood, Bone Marrow and Peripheral Blood
Kırcalı, Ekin
Ermiş, Gül Yavuz
Öztürk, Cemaleddin
Yilmaz, Hülya
Seval, Guldane Cengiz
Yıldırım, Yasin
Bozdag, Sinem Civriz
Toprak, Selami Kocak
Topcuoglu, Pervin
Ilhan, Osman
Beksac, Meral
Gurman, Gunhan
Yuksel, Meltem Kurt
Is It Safe to Continue Allogeneic Hematopoietic Cell Transplantation Via Cryopreservation during COVID-19 Pandemic?
title Is It Safe to Continue Allogeneic Hematopoietic Cell Transplantation Via Cryopreservation during COVID-19 Pandemic?
title_full Is It Safe to Continue Allogeneic Hematopoietic Cell Transplantation Via Cryopreservation during COVID-19 Pandemic?
title_fullStr Is It Safe to Continue Allogeneic Hematopoietic Cell Transplantation Via Cryopreservation during COVID-19 Pandemic?
title_full_unstemmed Is It Safe to Continue Allogeneic Hematopoietic Cell Transplantation Via Cryopreservation during COVID-19 Pandemic?
title_short Is It Safe to Continue Allogeneic Hematopoietic Cell Transplantation Via Cryopreservation during COVID-19 Pandemic?
title_sort is it safe to continue allogeneic hematopoietic cell transplantation via cryopreservation during covid-19 pandemic?
topic Poster Session - Graft Sources - Related, Matched and Mismatched Unrelated, Haplo, Autologous, Cord Blood, Bone Marrow and Peripheral Blood
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930036/
http://dx.doi.org/10.1016/S2666-6367(22)00500-0
work_keys_str_mv AT kırcalıekin isitsafetocontinueallogeneichematopoieticcelltransplantationviacryopreservationduringcovid19pandemic
AT ermisgulyavuz isitsafetocontinueallogeneichematopoieticcelltransplantationviacryopreservationduringcovid19pandemic
AT ozturkcemaleddin isitsafetocontinueallogeneichematopoieticcelltransplantationviacryopreservationduringcovid19pandemic
AT yilmazhulya isitsafetocontinueallogeneichematopoieticcelltransplantationviacryopreservationduringcovid19pandemic
AT sevalguldanecengiz isitsafetocontinueallogeneichematopoieticcelltransplantationviacryopreservationduringcovid19pandemic
AT yıldırımyasin isitsafetocontinueallogeneichematopoieticcelltransplantationviacryopreservationduringcovid19pandemic
AT bozdagsinemcivriz isitsafetocontinueallogeneichematopoieticcelltransplantationviacryopreservationduringcovid19pandemic
AT toprakselamikocak isitsafetocontinueallogeneichematopoieticcelltransplantationviacryopreservationduringcovid19pandemic
AT topcuoglupervin isitsafetocontinueallogeneichematopoieticcelltransplantationviacryopreservationduringcovid19pandemic
AT ilhanosman isitsafetocontinueallogeneichematopoieticcelltransplantationviacryopreservationduringcovid19pandemic
AT beksacmeral isitsafetocontinueallogeneichematopoieticcelltransplantationviacryopreservationduringcovid19pandemic
AT gurmangunhan isitsafetocontinueallogeneichematopoieticcelltransplantationviacryopreservationduringcovid19pandemic
AT yukselmeltemkurt isitsafetocontinueallogeneichematopoieticcelltransplantationviacryopreservationduringcovid19pandemic